Skip to content

Accepting New Patients • Major Insurance Accepted • Serving Rockville & Frederick

Refer a Patient Patient Portal

Menu

Home
About
Services
Conditions
Resources
Contact

Home
About
Services
Conditions
Resources
Contact

Call us (240) 599-1001 Free ConsultFree Consult

Call us (240) 599-1001

Free ConsultFree Consult

long-term effects

Articles tagged long-term effects from Bright Horizons Psychiatry.

Book a free consultationBook a free consultation Call (240) 599-1001Call (240) 599-1001

Categories

All articles
ADHD 7
Anxiety 10
Depression 21
Ketamine 1
OCD 4
Patient Resources 21
Spravato 13
TMS Therapy 16
Treatment-Resistant Depression 2

No articles found.

Take the First Step toward Feeling Better

You’re not alone. We’re here to help, with real care that works. Let’s talk. Even one conversation can change things.

Book your AppointmentBook your Appointment

Care that helps you feel better

Advanced Psychiatric care for treatment-resistant depression, Anxiety, OCD, and ADHD. Serving across Maryland.

Book AppointmentBook Appointment

Quick Links

Meet the team
Reviews
Testimonials
FAQs

Conditions

Depression
Anxiety
OCD
ADHD

Services

TMS
(Spravato®) Esketamine
IM Ketamine
Medication Management
Psychiatric Evaluation
Telehealth

North Bethesda Office

6000 Executive Blvd # 101
Rockville, MD 20852

Phone (240) 599-1001
Fax (240) 599-1002
Hours Mon – Fri: 8am – 6pm
Sat – Sun: Closed

Frederick Office

7360 Guilford Dr #100
Frederick, MD 21704

Phone (240) 599-1001
Fax (240) 599-1002
Hours Mon – Fri: 9am – 6pm
Sat – Sun: Closed

If you are experiencing a medical or psychiatric emergency, call 911 or go to the nearest emergency room. For mental health crises in the U.S., call or text 988 (Suicide & Crisis Lifeline). This website does not provide medical advice and is for informational purposes only.

SPRAVATO® (esketamine) is FDA-approved for treatment-resistant depression and depressive symptoms with acute suicidal ideation or behavior in adults, and is available only through a restricted REMS program. Treatment is administered in a certified healthcare setting with required post-dose monitoring. SPRAVATO® may cause sedation, dissociation, respiratory depression, and has a risk of abuse and misuse. Patients should not drive or operate machinery until the next day after a restful sleep.

IM ketamine therapy for psychiatric conditions is an off-label use of ketamine and is not FDA-approved for depression. Treatment is provided under medical supervision following clinical evaluation and informed consent. Individual results vary. Always discuss eligibility, risks, and alternatives with a licensed provider.

© 2026 Bright Horizons Psychiatry Managed by Devlistic

Privacy Policy Terms of Service Important Safety Information